KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 340.66 +4.62 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $336.04 | 52 Week High | $114.49 | |||
| Open | $342.15 | 52 Week Low | $75.17 | |||
| Day High | $349.24 | P/E | 94.37 | |||
| Day Low | $338.80 | EPS | $3.61 | |||
| Volume | 470,345 | |||||
| (AMEX: CSLLY) | Delayed: 20.34 +0.34 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.00 | 52 Week High | $45.60 | |||
| Open | $20.38 | 52 Week Low | $33.39 | |||
| Day High | $20.38 | P/E | N/A | |||
| Day Low | $20.17 | EPS | $0.00 | |||
| Volume | 316,371 | |||||
| (NASDAQ: TVTX) | Delayed: 56.68 -0.68 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.36 | 52 Week High | $ | |||
| Open | $57.95 | 52 Week Low | $ | |||
| Day High | $59.09 | P/E | N/A | |||
| Day Low | $56.67 | EPS | $ | |||
| Volume | 1,663,215 | |||||

